- Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.N Engl J Med. 2012; 366: 687-696
- Screening for colorectal cancer in individuals at average risk: current methods and emerging issues.JAMA Intern Med. 2014; 174: 10-11
- Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries.Cancer. 2012; 118: 3044-3052
- CIMP status of interval colon cancers: another piece to the puzzle.Am J Gastroenterol. 2010; 105: 1189-1195
- Avoiding and defending malpractice suits for postcolonoscopy cancer: advice from an expert witness.Clin Gastroenterol Hepatol. 2013; 11: 768-773
- Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.Gastroenterology. 2012; 143: 844-857
- Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials.Gastrointest Endosc. 2011; 73: 1240-1245
- A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy.Am J Gastroenterol. 1990; 85: 422-427
- A consensus document on bowel preparation before colonoscopy.Gastrointest Endosc. 2006; 63: 894-909
FDA News Release December 11, 2008: FDA requires new safety measures for oral sodium phosphate products to reduce risk of acute kidney injury: risk associated with both prescription and over-the-counter products. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116988.htm. Accessed January 29, 2014.
FDA Alert December 11, 2008: information for healthcare professionals: oral sodium phosphate products for bowel cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription). Available at: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm126084.htm. Accessed January 29, 2014.
- The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy.Arch Intern Med. 2008; 168: 593-597
- Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the U.S. Food and Drug Administration.Colorectal Dis. 2011; 13: e270-e275
- Association between oral sodium phosphate bowel preparations and kidney injury: a systematic review and meta-analysis.Am J Kidney Dis. 2009; 53: 448-456
- Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy, compared with polyethylene glycol.Clin Gastroenterol Hepatol. 2014; 12: 1514-1521
- 4-liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis.Clin Gastroenterol Hepatol. 2012; 10: 1225-1231
Conflicts of interest The author discloses no conflicts.